Related Experiment Videos
Pulmonary arterial histology and morphometry in systemic sclerosis: a case-control autopsy study
M R al-Sabbagh1, V D Steen, B C Zee
1Department of Medicine, University of Pittsburgh School of Medicine, PA 15261.
The Journal of Rheumatology
|August 1, 1989
Summary
Systemic sclerosis patients show increased pulmonary artery intima and luminal occlusion compared to controls. Limited cutaneous systemic sclerosis, particularly with pulmonary arterial hypertension, exhibits the most severe occlusion, explaining poor vasodilator response.
Area of Science:
- Cardiovascular Pathology
- Rheumatology
- Pulmonary Medicine
Background:
- Systemic sclerosis is a multisystem autoimmune disease.
- Pulmonary artery involvement is a known complication.
- Understanding vascular changes is crucial for patient outcomes.
Purpose of the Study:
- To compare pulmonary artery morphometrics in systemic sclerosis patients versus controls.
- To investigate differences based on disease subtype (limited vs. diffuse cutaneous) and renal crisis.
- To correlate vascular changes with pulmonary arterial hypertension and treatment response.
Main Methods:
- Morphometric analysis of pulmonary arteries from 58 systemic sclerosis patients and matched autopsy controls.
- Matched pairs analysis comparing intima area and luminal occlusion.
- Stratification by disease subtype (limited/diffuse cutaneous) and presence/absence of renal crisis.
Main Results:
- Increased intima area and luminal occlusion in systemic sclerosis patients across all artery sizes compared to controls.
- Statistically significant differences observed in large and medium-sized vessels.
- Greatest luminal occlusion found in limited cutaneous systemic sclerosis, especially those with pulmonary arterial hypertension.
Conclusions:
- Systemic sclerosis is associated with significant pulmonary artery remodeling.
- Luminal occlusion in pulmonary arteries is a key feature, particularly in limited cutaneous disease.
- These findings provide a rationale for the limited efficacy of vasodilator therapy in some systemic sclerosis patients with pulmonary arterial hypertension.